SEARCH

SEARCH BY CITATION

References

  • Algino, K.M., Thomason, R.W., King, D.E., Montiel, M.M. & Craig, F.E. (1996) CD20 (pan-B cell antigen) expression on bone marrow-derived T cells. American Journal of Clinical Pathology, 106, 7881.
  • Antia, R., Ganusov, V.V. & Ahmed, R. (2005) The role of models in understanding CD8+ T-cell memory. Nature Reviews. Immunology, 5, 101111.
  • Gandhi, M.K. & Khanna, R. (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. The Lancet Infectious Diseases, 4, 725738.
  • Gandhi, M.K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. & Khanna, R. (2006a) Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood, 108, 22802289.
  • Gandhi, M.K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P.J., Prince, H.M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J.F. & Khanna, R. (2006b) Plasma Epstein–Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12, 460464.
  • Kaplan, L.D., Lee, J.Y., Ambinder, R.F., Sparano, J.A., Cesarman, E., Chadburn, A., Levine, A.M. & Scadden, D.T. (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood, 106, 15381543.
  • Neelapu, S.S., Kwak, L.W., Kobrin, C.B., Reynolds, C.W., Janik, J.E., Dunleavy, K., White, T., Harvey, L., Pennington, R., Stetler-Stevenson, M., Jaffe, E.S., Steinberg, S.M., Gress, R., Hakim, F. & Wilson, W.H. (2005) Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nature Medicine, 11, 986991.
  • Savoldo, B., Rooney, C.M., Quiros-Tejeira, R.E., Caldwell, Y., Wagner, H.J., Lee, T., Finegold, M.J., Dotti, G., Heslop, H.E. & Goss, J.A. (2005) Cellular immunity to Epstein–Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. American Journal of Transplantation, 5, 566572.
  • Serafini, M., Manganini, M., Borleri, G., Bonamino, M., Imberti, L., Biondi, A., Golay, J., Rambaldi, A. & Introna, M. (2004) Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease. Human Gene Therapy, 15, 6376.
  • Shen, H., Whitmire, J.K., Fan, X., Shedlock, D.J., Kaech, S.M. & Ahmed, R. (2003) A specific role for B cells in the generation of CD8 T -cell memory by recombinant Listeria monocytogenes. Journal of Immunology, 170, 14431451.
  • Tan, L.C., Gudgeon, N., Annels, N.E., Hansasuta, P., O'Callaghan, C.A., Rowland-Jones, S., McMichael, A.J., Rickinson, A.B. & Callan, M.F. (1999) A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. Journal of Immunology, 162, 18271835.
  • Young, L.S. & Rickinson, A.B. (2004) Epstein–Barr virus: 40 years on. Nature Reviews. Cancer, 4, 757768.